The man's family later sued OptumRx and Walgreens, claiming they didn't offer alternatives after his regular inhaler's price ...
Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations ...
For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...
As the school year prepares to get underway, health experts are warning whānau that the weeks ahead are the most dangerous ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase in mortality and morbidity in recent years, affecting all age groups ...
Mepolizumab significantly reduced asthma exacerbations and oral corticosteroid use in patients with SEA, with or without CRSwNP, in a real-world setting. Improvements in lung function and asthma ...
A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the widely-used salbutamol inhaler. The corresponding study was published in The Lancet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results